Ann Rheum Dis -- Table of Contents (65 [Supplement 3 ])

Subscribe here
Activate your subscription

Home > Volume 65, Suppl 3

Receive tables of contents (and more) by e-mail each issue: Subscribe to Customised @lerts

November 2006 (Volume 65, Supplement 3 ). [Index by author]

Advances in targeted therapies VIII

Find articles in this issue containing these words: [Search ALL Issues]

	Advances in targeted therapies VIII F C Breedveld, J R Kalden, and J S Smolen Ann Rheum Dis 2006; 65 (Supplement 3 ): iii1. doi:10.1136/ard.2006.058610 [Extract] [Full text] [PDF] [Request Permissions]

	Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006 D E Furst, F C Breedveld, J R Kalden, J S Smolen, G R Burmester, P Emery, E C Keystone, M H Schiff, P L C M van Riel, M E Weinblatt, and M H Weisman Ann Rheum Dis 2006; 65 (Supplement 3 ): iii2-iii15. doi:10.1136/ard.2006.061937 [Extract] [Full text] [PDF] [Request Permissions]

	More relevant, precise, and efficient items for assessment of physical function and disability: moving beyond the classic instruments J F Fries, B Bruce, J Bjorner, and M Rose Ann Rheum Dis 2006; 65 (Supplement 3 ): iii16-iii21. doi:10.1136/ard.2006.059279 [Abstract] [Full text] [PDF] [Request Permissions]

	Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases? D D Gladman Ann Rheum Dis 2006; 65 (Supplement 3 ): iii22-iii24. doi:10.1136/ard.2006.058453 [Extract] [Full text] [PDF] [Request Permissions]

	Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different? M M Ward Ann Rheum Dis 2006; 65 (Supplement 3 ): iii25-iii28. doi:10.1136/ard.2006.058461 [Abstract] [Full text] [PDF] [Request Permissions]

	Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis M I Koenders, L A B Joosten, and W B van den Berg Ann Rheum Dis 2006; 65 (Supplement 3 ): iii29-iii33. doi:10.1136/ard.2006.058529 [Abstract] [Full text] [PDF] [Request Permissions]

	The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity M P Cancro Ann Rheum Dis 2006; 65 (Supplement 3 ): iii34-iii36. doi:10.1136/ard.2006.058412 [Abstract] [Full text] [PDF] [Request Permissions]

	Role of nitric oxide in the regulation of T cell functions W Niedbala, B Cai, and F Y Liew Ann Rheum Dis 2006; 65 (Supplement 3 ): iii37-iii40. doi:10.1136/ard.2006.058446 [Abstract] [Full text] [PDF] [Request Permissions]

	Can studies of tolerance ever lead to therapy? H von Boehmer Ann Rheum Dis 2006; 65 (Supplement 3 ): iii41-iii43. doi:10.1136/ard.2006.058396 [Abstract] [Full text] [PDF] [Request Permissions]

	Pharmacoeconomics: friend or foe? M Drummond Ann Rheum Dis 2006; 65 (Supplement 3 ): iii44-iii47. doi:10.1136/ard.2006.058602 [Abstract] [Full text] [PDF] [Request Permissions]

	Natalizumab and progressive multifocal leucoencephalopathy J R Berger Ann Rheum Dis 2006; 65 (Supplement 3 ): iii48-iii53. doi:10.1136/ard.2006.058404 [Abstract] [Full text] [PDF] [Request Permissions]

	Serious infections with antirheumatic therapy: are biologicals worse? K L Winthrop Ann Rheum Dis 2006; 65 (Supplement 3 ): iii54-iii57. doi:10.1136/ard.2006.058503 [Abstract] [Full text] [PDF] [Request Permissions]

	Treating rheumatic diseases in pregnancy: dos and don’ts M D Lockshin Ann Rheum Dis 2006; 65 (Supplement 3 ): iii58-iii60. doi:10.1136/ard.2006.058420 [Abstract] [Full text] [PDF] [Request Permissions]

	IL-32, a novel cytokine with a possible role in disease C A Dinarello and S-H Kim Ann Rheum Dis 2006; 65 (Supplement 3 ): iii61-iii64. doi:10.1136/ard.2006.058511 [Abstract] [Full text] [PDF] [Request Permissions]

	Heat shock proteins induce T cell regulation of chronic inflammation F Hauet-Broere, L Wieten, T Guichelaar, S Berlo, R van der Zee, and W Van Eden Ann Rheum Dis 2006; 65 (Supplement 3 ): iii65-iii68. doi:10.1136/ard.2006.058495 [Abstract] [Full text] [PDF] [Request Permissions]

	Interleukin-7 induced immunopathology in arthritis S A Y Hartgring, J W J Bijlsma, F P J G Lafeber, and J A G van Roon Ann Rheum Dis 2006; 65 (Supplement 3 ): iii69-iii74. doi:10.1136/ard.2006.058479 [Abstract] [Full text] [PDF] [Request Permissions]

	Use of cell permeable NBD peptides for suppression of inflammation I Strickland and S Ghosh Ann Rheum Dis 2006; 65 (Supplement 3 ): iii75-iii82. doi:10.1136/ard.2006.058438 [Abstract] [Full text] [PDF] [Request Permissions]

	Mitogen activated protein kinase inhibitors: where are we now and where are we going? S E Sweeney and G S Firestein Ann Rheum Dis 2006; 65 (Supplement 3 ): iii83-iii88. doi:10.1136/ard.2006.058388 [Abstract] [Full text] [PDF] [Request Permissions]

	Targeted therapies: summary clinical trials working group M E Weinblatt and P L C M van Riel Ann Rheum Dis 2006; 65 (Supplement 3 ): iii89. doi:10.1136/ard.2006.060939 [Extract] [Full text] [PDF] [Request Permissions]

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstracts' button. To see one abstract at a time, click its [Abstract] link.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs

Show me all >>